Developmental ability of embryos produced from oocytes with fragile oolemma by intracytoplasmic sperm injection
- PMID: 27639997
- PMCID: PMC5171884
- DOI: 10.1007/s10815-016-0811-4
Developmental ability of embryos produced from oocytes with fragile oolemma by intracytoplasmic sperm injection
Abstract
Purpose: In intracytoplasmic sperm injection (ICSI) of oocytes with a fragile oolemma (fragile oocytes), breakage can occur at injection. In this study, we produced embryos from oocytes with a fragile and normal oolemma (normal oocytes) by ICSI and compared their ability to be fertilized and develop in vitro. We also investigated whether fragile oocyte-derived embryos could implant after blastocyst transfer to determine whether fragile oocytes should be used for assisted reproductive technology treatment.
Methods: Oocytes were divided into three groups-normal oocytes from cycles containing no fragile oocytes (group A), normal oocytes from cycles containing at least one fragile oocyte (group B), and fragile oocytes (group C), and their fertilization abilities after ICSI and the developmental abilities of resultant embryos were compared.
Results: The fertilization rate in group C (65.3 %) was significantly (P < 0.01) lower than those in groups A (84.6 %) and B (86.9 %), and the degeneration rate in group C (24.2 %) was significantly (P < 0.01) higher than those in groups A (0.71 %) and B (0.28 %). However, there were no significant differences in the blastocyst formation rates (59.7-67.5 %) of embryos among the different groups. In addition, the pregnancy rate after transfer of blastocysts in group C (50.0 %) was not significantly different from those in groups A (35.6 %) and B (45.8 %).
Conclusions: The fertilization ability after ICSI of fragile oocytes is lower than that of normal oocytes but the resultant embryos have the same developmental ability as those of normal oocyte-derived embryos.
Keywords: Embryo; In vitro fertilization; Intracytoplasmic sperm injection; Oocyte plasma membrane; Oolemma; Time-lapse incubator.
Conflict of interest statement
The authors declare that they have no conflict of interest. Research involving human participants This study was approved by the Institutional Review Board of AIIKUKAI Medical Corporation. Informed consent Written informed consent for their treatment and for their outcomes to be described was obtained from all patients.
Figures
Similar articles
-
Vitrification of in vitro matured oocytes diminishes embryo development potential before but not after embryo genomic activation.J Assist Reprod Genet. 2016 Feb;33(2):231-6. doi: 10.1007/s10815-015-0637-5. Epub 2015 Dec 21. J Assist Reprod Genet. 2016. PMID: 26685678 Free PMC article.
-
Fertilization, embryo development, and clinical outcome of immature oocytes from stimulated intracytoplasmic sperm injection cycles.Fertil Steril. 2007 May;87(5):1022-7. doi: 10.1016/j.fertnstert.2006.08.110. Epub 2007 Jan 29. Fertil Steril. 2007. PMID: 17261289
-
A comparison of the clinical outcomes of embryos derived from intracytoplasmic sperm injection after early fertilization check and conventional insemination using sibling oocytes.Arch Gynecol Obstet. 2016 Apr;293(4):887-92. doi: 10.1007/s00404-015-3946-0. Epub 2015 Nov 4. Arch Gynecol Obstet. 2016. PMID: 26538354
-
Live birth from a blastocyst derived from a conjoined oocyte in a frozen embryo transfer cycle: a case report and a literature review.J Assist Reprod Genet. 2022 Jun;39(6):1351-1357. doi: 10.1007/s10815-022-02465-5. Epub 2022 Mar 23. J Assist Reprod Genet. 2022. PMID: 35320445 Free PMC article. Review.
-
Intracytoplasmic Sperm Injection, Embryo Culture, and Transfer of In Vitro-Produced Blastocysts.Vet Clin North Am Equine Pract. 2016 Dec;32(3):401-413. doi: 10.1016/j.cveq.2016.07.003. Epub 2016 Oct 8. Vet Clin North Am Equine Pract. 2016. PMID: 27726990 Review.
Cited by
-
Oocyte Degeneration After ICSI Is Not an Indicator of Live Birth in Young Women.Front Endocrinol (Lausanne). 2021 Aug 16;12:705733. doi: 10.3389/fendo.2021.705733. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34484119 Free PMC article.
-
Evaluating the value of day 0 of an ICSI cycle on indicating laboratory outcome.Sci Rep. 2020 Nov 9;10(1):19325. doi: 10.1038/s41598-020-75164-9. Sci Rep. 2020. PMID: 33168856 Free PMC article.
-
Good practice recommendations for the use of time-lapse technology†.Hum Reprod Open. 2020 Mar 19;2020(2):hoaa008. doi: 10.1093/hropen/hoaa008. eCollection 2020. Hum Reprod Open. 2020. PMID: 32206731 Free PMC article.
-
Association of follicular fluid volume with membrane stretchability of human metaphase II oocytes following the gonadotropin-releasing hormone agonist protocol during intracytoplasmic sperm injection.Reprod Med Biol. 2018 May 11;17(3):283-288. doi: 10.1002/rmb2.12102. eCollection 2018 Jul. Reprod Med Biol. 2018. PMID: 30013430 Free PMC article.
-
The association of follicular fluid volume with human oolemma stretchability during intracytoplasmic sperm injection.Clin Exp Reprod Med. 2017 Sep;44(3):126-131. doi: 10.5653/cerm.2017.44.3.126. Epub 2017 Sep 26. Clin Exp Reprod Med. 2017. PMID: 29026718 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
